Suppr超能文献

用于在工程化血管组织环内递送生长因子的含微球细胞自组装

Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings.

作者信息

Strobel Hannah A, Dikina Anna D, Levi Karen, Solorio Loran D, Alsberg Eben, Rolle Marsha W

机构信息

1 Department of Biomedical Engineering, Worcester Polytechnic Institute , Worcester, Massachusetts.

2 Department of Biomedical Engineering, Case Western Reserve University , Cleveland, Ohio.

出版信息

Tissue Eng Part A. 2017 Feb;23(3-4):143-155. doi: 10.1089/ten.TEA.2016.0260. Epub 2016 Dec 6.

Abstract

Cellular self-assembly has been used to generate living tissue constructs as an alternative to seeding cells on or within exogenous scaffold materials. However, high cell and extracellular matrix density in self-assembled constructs may impede diffusion of growth factors during engineered tissue culture. In the present study, we assessed the feasibility of incorporating gelatin microspheres within vascular tissue rings during cellular self-assembly to achieve growth factor delivery. To assess microsphere incorporation and distribution within vascular tissue rings, gelatin microspheres were mixed with a suspension of human smooth muscle cells (SMCs) at 0, 0.2, or 0.6 mg per million cells and seeded into agarose wells to form self-assembled cell rings. Microspheres were distributed throughout the rings and were mostly degraded within 14 days in culture. Rings with microspheres were cultured in both SMC growth medium and differentiation medium, with no adverse effects on ring structure or mechanical properties. Incorporated gelatin microspheres loaded with transforming growth factor beta 1 stimulated smooth muscle contractile protein expression in tissue rings. These findings demonstrate that microsphere incorporation can be used as a delivery vehicle for growth factors within self-assembled vascular tissues.

摘要

细胞自组装已被用于生成活组织构建体,作为在外源支架材料上或内部接种细胞的替代方法。然而,自组装构建体中高细胞和细胞外基质密度可能会在工程组织培养过程中阻碍生长因子的扩散。在本研究中,我们评估了在细胞自组装过程中将明胶微球掺入血管组织环以实现生长因子递送的可行性。为了评估微球在血管组织环中的掺入和分布情况,将明胶微球与每百万细胞0、0.2或0.6毫克的人平滑肌细胞(SMC)悬浮液混合,并接种到琼脂糖孔中以形成自组装细胞环。微球分布在整个环中,并且在培养14天内大部分被降解。含有微球的环在SMC生长培养基和分化培养基中培养,对环结构或机械性能没有不利影响。掺入载有转化生长因子β1的明胶微球可刺激组织环中平滑肌收缩蛋白的表达。这些发现表明,微球掺入可作为自组装血管组织中生长因子的递送载体。

相似文献

4
Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities.组织工程血管的具有空间控制异质性的组装。
Tissue Eng Part A. 2018 Oct;24(19-20):1492-1503. doi: 10.1089/ten.TEA.2017.0492. Epub 2018 Aug 20.
7
Customizable engineered blood vessels using 3D printed inserts.使用3D打印插入物的可定制工程血管。
Methods. 2016 Apr 15;99:20-7. doi: 10.1016/j.ymeth.2015.12.015. Epub 2015 Dec 28.

引用本文的文献

7
A Method for High-Throughput Robotic Assembly of Three-Dimensional Vascular Tissue.一种高通量机器人组装三维血管组织的方法。
Tissue Eng Part A. 2019 Sep;25(17-18):1251-1260. doi: 10.1089/ten.TEA.2018.0288. Epub 2019 Aug 9.
9
Chitosan/gelatin scaffolds support bone regeneration.壳聚糖/明胶支架支持骨再生。
J Mater Sci Mater Med. 2018 May 5;29(5):59. doi: 10.1007/s10856-018-6064-2.
10
Assembly of Tissue-Engineered Blood Vessels with Spatially Controlled Heterogeneities.组织工程血管的具有空间控制异质性的组装。
Tissue Eng Part A. 2018 Oct;24(19-20):1492-1503. doi: 10.1089/ten.TEA.2017.0492. Epub 2018 Aug 20.

本文引用的文献

2
Tissue-engineered blood vessels as promising tools for testing drug toxicity.组织工程血管作为测试药物毒性的有前景的工具。
Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1021-4. doi: 10.1517/17425255.2015.1047342. Epub 2015 May 31.
4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验